OPT — Opthea Income Statement
0.000.00%
HealthcareAdventurousMicro Cap
Annual income statement for Opthea, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.069 | 0.091 | 0.108 | 0.125 | 0.025 |
| Cost of Revenue | |||||
| Gross Profit | -0.36 | -0.07 | -0.058 | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 39.7 | 96.7 | 150 | 192 | 170 |
| Operating Profit | -39.7 | -96.6 | -150 | -192 | -170 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -50.3 | -99.1 | -148 | -230 | -170 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -45.3 | -92.8 | -143 | -220 | -163 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -45.3 | -92.8 | -143 | -220 | -163 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -45.3 | -92.8 | -143 | -220 | -163 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.123 | -0.229 | -0.28 | -0.345 | -0.133 |